NasdaqCM - Nasdaq Real Time Price USD

The Oncology Institute, Inc. (TOI)

Compare
0.3117
+0.0100
+(3.31%)
At close: January 13 at 4:00:01 PM EST
Loading Chart for TOI
DELL
  • Previous Close 0.3017
  • Open 0.3000
  • Bid 0.3055 x 100
  • Ask 0.3188 x 100
  • Day's Range 0.2723 - 0.3189
  • 52 Week Range 0.1250 - 2.4500
  • Volume 516,581
  • Avg. Volume 1,886,510
  • Market Cap (intraday) 23.552M
  • Beta (5Y Monthly) 0.62
  • PE Ratio (TTM) --
  • EPS (TTM) -0.7700
  • Earnings Date Mar 25, 2025 - Mar 31, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.

theoncologyinstitute.com

800

Full Time Employees

December 31

Fiscal Year Ends

Recent News: TOI

View More

Performance Overview: TOI

Trailing total returns as of 1/13/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

TOI
2.59%
S&P 500
1.20%

1-Year Return

TOI
84.94%
S&P 500
22.00%

3-Year Return

TOI
96.44%
S&P 500
23.48%

5-Year Return

TOI
96.79%
S&P 500
78.73%

Compare To: TOI

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: TOI

View More

Valuation Measures

Annual
As of 1/13/2025
  • Market Cap

    23.55M

  • Enterprise Value

    99.10M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.06

  • Price/Book (mrq)

    1.52

  • Enterprise Value/Revenue

    0.26

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -19.81%

  • Return on Assets (ttm)

    -19.42%

  • Return on Equity (ttm)

    -125.59%

  • Revenue (ttm)

    361.07M

  • Net Income Avi to Common (ttm)

    -58.51M

  • Diluted EPS (ttm)

    -0.7700

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    46.36M

  • Total Debt/Equity (mrq)

    414.32%

  • Levered Free Cash Flow (ttm)

    -23.95M

Research Analysis: TOI

View More

Company Insights: TOI

Research Reports: TOI

View More

People Also Watch